Detalhe da pesquisa
1.
3D chromatin remodeling potentiates transcriptional programs driving cell invasion.
Proc Natl Acad Sci U S A
; 119(36): e2203452119, 2022 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36037342
2.
Evaluation of a 'plug and play' nanoflow liquid chromatography system for MS-based proteomic characterization of clinical FFPE specimens.
Expert Rev Proteomics
; 20(4-6): 87-92, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37309581
3.
A Non-Hazardous Deparaffinization Protocol Enables Quantitative Proteomics of Core Needle Biopsy-Sized Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue Specimens.
Int J Mol Sci
; 23(8)2022 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35457260
4.
Precise Quantitation of PTEN by Immuno-MRM: A Tool To Resolve the Breast Cancer Biomarker Controversy.
Anal Chem
; 93(31): 10816-10824, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34324311
5.
A multiplexed, automated immuno-matrix assisted laser desorption/ionization mass spectrometry assay for simultaneous and precise quantitation of PTEN and p110α in cell lines and tumor tissues.
Analyst
; 146(21): 6566-6575, 2021 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34585690
6.
Using Two Peptide Isotopologues as Internal Standards for the Streamlined Quantification of Low-Abundance Proteins by Immuno-MRM and Immuno-MALDI.
Anal Chem
; 92(18): 12407-12414, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32786432
7.
Breast cancer mammospheres secrete Adrenomedullin to induce lipolysis and browning of adjacent adipocytes.
BMC Cancer
; 20(1): 784, 2020 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32819314
8.
Immuno-Matrix-Assisted Laser Desorption/Ionization Assays for Quantifying AKT1 and AKT2 in Breast and Colorectal Cancer Cell Lines and Tumors.
Anal Chem
; 89(19): 10592-10600, 2017 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28853539
9.
The identification of challenges in tissue collection for biomarker studies: the Q-CROC-03 neoadjuvant breast cancer translational trial experience.
Mod Pathol
; 30(11): 1567-1576, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28752846
10.
Glycoproteomic comparison of clinical triple-negative and luminal breast tumors.
J Proteome Res
; 14(3): 1376-88, 2015 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25658377
11.
Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine.
Mod Pathol
; 26(11): 1413-24, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23743930
12.
A micro-flow, high-pH, reversed-phase peptide fractionation and collection system for targeted and in-depth proteomics of low-abundance proteins in limiting samples.
MethodsX
; 11: 102306, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37577163
13.
The Mutational Spectrum of Pre- and Post-Neoadjuvant Chemotherapy Triple-Negative Breast Cancers.
Genes (Basel)
; 15(1)2023 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38254917
14.
Healthcare policy by other means: Cancer clinical research as "oncopolicy".
Soc Sci Med
; 292: 114576, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34826765
15.
HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin.
Oncogene
; 41(12): 1701-1717, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35110681
16.
CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model.
Int J Cancer
; 129(1): 225-32, 2011 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20830712
17.
Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner.
J Immunol
; 182(10): 5994-6002, 2009 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19414750
18.
Early, On-Treatment Levels and Dynamic Changes of Genomic Instability in Circulating Tumor DNA Predict Response to Treatment and Outcome in Metastatic Breast Cancer Patients.
Cancers (Basel)
; 13(6)2021 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33809567
19.
STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer.
Nat Commun
; 12(1): 3299, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083537
20.
Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancers.
Breast Cancer Res Treat
; 120(1): 47-57, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19301121